Introduction: Ascletis Biotechnology (Hangzhou) Co., Ltd. is an emerging biotechnology company dedicated to the discovery, development and commercialization of important new treatments for cancer and infectious diseases. Ascletis focuses on the clinical development and production of innovative drugs for the growing Chinese pharmaceutical market.

Legal representative: WU JINZI JASON

Establishment date: 2013-04-26

Registered capital: US$100.600162 million

Industrial and commercial Registration number: 330100400046508

Enterprise type: Limited liability company (solely owned by foreign legal persons)

Company address: No. 198 Qidi Road, Xiaoshan Economic and Technological Development Zone, Xiaoshan District, Hangzhou City, Zhejiang Province Hangzhou Bay Information Room 1101, Tower D, Hong Kong